Stocksigma LogoStocksigma Logo

Vimta Labs Delivers Steady Q2 FY27 Results With Total Income Up 9.9% YoY

Vimta Labs reported Q2 FY27 total income of ₹1,149 Mn, rising 9.9% YoY and 1.8% QoQ, driven by core pharmaceutical and food testing alongside initial

Vimta Labs Delivers Steady Q2 FY27 Results With Total Income Up 9.9% YoY

Vimta Labs Ltd · Press Release · 30 Oct 2026, 7:28 pm

Vimta Labs Delivers Steady Q2 FY27 Results With Total Income Up 9.9% YoY Vimta Labs reported Q2 FY27 total income of ₹1,149 Mn, rising 9.9% YoY and 1.8% QoQ, driven by core pharmaceutical and food testing alongside initial revenues from biologics CRAD services. EBITDA grew 10.5% YoY to ₹408 Mn, delivering a 35.5% margin, while PAT rose 3.5% YoY to ₹206 Mn with a 17.9% margin. Basic EPS reached ₹4.6. For H1 FY27, total income increased 11.8% YoY to ₹2,278 Mn and EBITDA advanced 13.2% YoY to ₹819 Mn with a 36.0% margin.

Original exchange filing (PDF)

More announcements from Vimta Labs Ltd

All Vimta Labs Ltd announcements